TNF and irritable bowel syndrome: Given increasing evidence that low-grade inflammation and dysbiosis contribute to IBS symptoms, modulation of TNF-α may offer therapeutic benefits in specific IBS subtypes, especially those characterized by immune activation or post-infectious features.